HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gilles Courtois Selected Research

hypohidrotic Ectodermal dysplasia with immune deficiency

3/2006A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.
10/2003A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
10/2002The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes.
6/2002Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gilles Courtois Research Topics

Disease

6Inflammation (Inflammations)
01/2016 - 08/2003
4Neoplasms (Cancer)
06/2011 - 01/2004
4Inborn Genetic Diseases (Disease, Hereditary)
08/2010 - 10/2002
4hypohidrotic Ectodermal dysplasia with immune deficiency
03/2006 - 06/2002
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
07/2012 - 03/2006
3Ectodermal Dysplasia (Aplasia Cutis Congenita)
03/2006 - 10/2002
2Incontinentia Pigmenti (Bloch Sulzberger Syndrome)
08/2010 - 10/2002
1Hearing Loss (Hearing Impairment)
08/2021
1Non-alcoholic Fatty Liver Disease
01/2020
1Obesity
01/2016
1Glucose Intolerance
01/2016
1Hematologic Diseases (Blood Diseases)
07/2012
1Mycosis Fungoides
07/2012
1Virus Diseases (Viral Diseases)
11/2008
1Infections
10/2006
1Retinoblastoma (Glioblastoma, Retinal)
12/2004
1Bacterial Infections (Bacterial Infection)
10/2003
1Necrosis
08/2003
1Carcinogenesis
08/2003
1Osteopetrosis
10/2002

Drug/Important Bio-Agent (IBA)

12NF-kappa B (NF-kB)IBA
09/2010 - 06/2002
3Phosphotransferases (Kinase)IBA
01/2020 - 11/2008
3Transcription Factors (Transcription Factor)IBA
04/2015 - 08/2003
3I-kappa B KinaseIBA
11/2008 - 10/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2006 - 10/2003
2Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2008
2Protein Kinases (Protein Kinase)IBA
01/2020 - 01/2016
2Peptides (Polypeptides)IBA
03/2006 - 12/2004
2NF-KappaB Inhibitor alphaIBA
01/2004 - 10/2003
2Codon (Codons)IBA
10/2002 - 06/2002
1Biomarkers (Surrogate Marker)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Insulin (Novolin)FDA Link
01/2016
1plastinIBA
07/2012
1Deubiquitinating EnzymesIBA
06/2011
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
08/2010
1Antineoplastic Agents (Antineoplastics)IBA
02/2008
1AS602868IBA
02/2008
1Inflammation MediatorsIBA
10/2006
1CytokinesIBA
10/2006
1DNA (Deoxyribonucleic Acid)IBA
03/2006
1Alanine (L-Alanine)FDA Link
03/2006
1LipopolysaccharidesIBA
03/2006
1Glycine (Aminoacetic Acid)FDA LinkGeneric
03/2006
1LigandsIBA
10/2003
1Serine (L-Serine)FDA Link
10/2003
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
08/2003
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
08/2003
1EctodysplasinsIBA
10/2002
1Edar ReceptorIBA
10/2002

Therapy/Procedure

1Hearing Aids (Hearing Aid)
08/2021